Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): A retrospective study of 46 cases (1999-2004)

Journal of Veterinary Internal Medicine

Volumn 20, Issue 6, 2006, Pages 1389-1397

  Risbon, Rebecca E ^a   De Lorimier, L P ^c   Skorupski, K ^b   Burgess, K E ^a,j   Bergman, P J ^d   Carreras, J ^e   Hahn, K ^e   LeBlanc, A ^f,k   Turek, M ^g,l   Impellizeri, J ^h,m   Fred III, R ^a   Wojcieszyn, J W ⁱ   Drobatz, K ^b   Clifford, C A ^a  

^a RED BANK VETERINARY HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Veterinary Teaching Hospital   (United States)

^d ANIMAL MEDICAL CENTER   (United States)

^e Gulf Coast Veterinary Surgery   (United States)

^f Parc d'activités Mermoz   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

^h Veterinary Oncology Services PLLC   (United States)

ⁱ IHC Services   (United States)

^j TUFTS UNIVERSITY   (United States)

^k UNIVERSITY OF TENNESSEE   (United States)

^l Angell Memorial Animal Hospital   (United States)

^m Hudson Highlands Vet Medical Group   (United States)

more..

Author keywords

Alkylator; Chemotherapy; Epitheliotropic lymphoma; Mycosis fungoides; Nitrosourea; Skin

Indexed keywords

ALKYLATING AGENT; LOMUSTINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MULTICENTER STUDY; MYCOSIS FUNGOIDES; PATHOLOGY; RETROSPECTIVE STUDY; SKIN TUMOR; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; LOMUSTINE; MALE; MYCOSIS FUNGOIDES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 33845693997     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[1389:ROCCEL]2.0.CO;2     Document Type: Article

References (27)

1. Moore PF, Olivry T, Naydan D. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells. Am J Pathol 1994;144:421-429.
2. Fivenson DP, Saed GM, Beck ER, et al. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma. J Invest Derm 1994;102:227-230.
3. Scott DW, Miller WH, Griffin CE. Muller & Kirk's Small Animal Dermatology, 6th ed. Philadelphia. PA: WB Saunders; 2001:1131-1340.
4. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Eng J Med 2004;350:1978-1988.
5. de Lorimier LP. Updates on the management of canine epitheliotropic cutaneous T-cell lymphoma. Vet Clin Small Anim 2006;36:213-228.
6. Morielio KA, MacEwen EG, Shultz KT. PEG-L-asparaginase in the treatment of canine Epitheliotropic lymphoma and histiocytic proliferation dermatitis. Advances in Veterinary Dermatology, Vol 2. Oxford: Pergamon Press; 1993:293-299.
7. Vail DM, Kravis LD, Cooley AJ, et al. Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors. Cancer Chemother Pharmacol 1997;39:410-416.
8. Shadduck JA, Reedy L, Lawton G, et al. A canine cutaneous lymphoproliferative disease resembling mycosis fungoides in man. Vet Pathol 1978;15:716-724.
9. McKeever PJ, Grindem CB, Stevens JB, et al. Canine cutaneous lymphoma. J Am Vet Med Assoc 1982;180:531-536.
10. Doe R, Zackheim HS, Hill JR. Canine epidermotropic cutaneous lymphoma. Am J Dermatopathol 1988;10:80-86.
11. Thrall MA, Macy DW, Snyder SP, et al. Cutaneous lymphosarcoma and leukemia in a dog resembling Sézary syndrome in man. Vet Pathol 1984;21:182-186.
12. Donaldson D, Day MJ. Epitheliotropic lymphoma (mycosis fungoides) presenting as blepharoconjunctivitis in an Irish setter. J Small Anim Pract 2000;41:317-320.
13. Ridyard AE, Rhind SM, French AT, et al. Myasthenia gravis associated with cutaneous lymphoma in a dog. J Small Anim Pract 2000;41:348-351.
14. Maiolino P, DeVico G. Primary epitheliotropic T-cell lymphoma of the urinary bladder in a dog. Vet Pathol 2000;37: 184-186.
15. Lemarié SL, Eddlestone SM. Treatment of cutaneous T-cell lymphoma with dacarbazine in a dog. Veterinary Dermatology 1997;8:41-46.
16. White SD, Rosychuk RA, Scott KV, et al. Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs. J Am Vet Med Assoc 1993;3:387-391.
17. DeBoer DJ, Turrel JM, Moore PF. Mycosis fungoides in a dog: demonstration of T-cell specificity and response to radiotherapy. J Am Anim Hosp Assoc 1990;26:566-572.
18. Rosenkrantz WS, Griffin CE, Barr RJ. Clinical evaluation of cyclosporine in animal models with cutaneous immune-mediated disease and epitheliotropic lymphoma. J Am Hosp Assoc 1989;25:377-384.
19. Williams LE, Rassnick KM, Power HT, et al. CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med 2006;20:136-143.
20. Vail DM. Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Comp Oncology 2004;2:194-213.
21. Foster AP, Evans E, Kerlin RL, Vail DM. Cutaneous T-cell lymphoma with sezary syndrome in a dog. Vet Clin Path 1997;26:188-192.
22. Cole SP, Tannock IF. Drug Resistance. In: Tannok IF, Hill RP, eds. The Basic Science of Oncology. New York, NY: McGraw-Hill; 2005:376-399.
23. Moore AS, London CA, Wood CA, et al. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999;13:395-398.
24. Kristal O, Rassnick KM, Gliatto JM, et al. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. J Vet Intern Med 2004;18:75-80.
25. Valerius KD, Ogilvie GK, Mallinckrodt CH, et al. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). J Am Vet Med Assoc 1997;210:512-516.
26. MacDonald VS, Thamm DH, Kurzman ID, et al. Does L-Asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma? J Vet Intern Med 2005;19:732-736.
27. Czasch S, Risse K, Baumgartner W. Central nervous system metastasis of a cutaneous epitheliotropic lymphosarcoma in a dog. J Comp Path 2000;123:59-63.